메뉴 건너뛰기




Volumn 85, Issue 9, 2015, Pages 790-798

Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease

(28)  Wang, Fen a   Gordon, Brian A a   Ryman, Davis C a   Ma, Shengmei a,m   Xiong, Chengjie b   Hassenstab, Jason a,l   Goate, Alison a   Fagan, Anne M a,j   Cairns, Nigel J a,k   Marcus, Daniel S g   McDade, Eric a,n   Ringman, John M a,o   Graff Radford, Neill R a,p   Ghetti, Bernardino a   Farlow, Martin R c   Sperling, Reisa d   Salloway, Steve e   Schofield, Peter R f   Masters, Colin L h   Martins, Ralph N g   more..


Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; APOLIPOPROTEIN E4; PITTSBURGH COMPOUND B; AMYLOID PRECURSOR PROTEIN; APP PROTEIN, HUMAN; PRESENILIN 1; PRESENILIN 2; PSEN1 PROTEIN, HUMAN; PSEN2 PROTEIN, HUMAN;

EID: 84951773904     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001903     Document Type: Article
Times cited : (23)

References (40)
  • 1
    • 0026597063 scopus 로고
    • Alzheimer's disease: The amyloid cascade hypothesis
    • Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992;256:184-185.
    • (1992) Science , vol.256 , pp. 184-185
    • Hardy, J.A.1    Higgins, G.A.2
  • 2
    • 72049130805 scopus 로고    scopus 로고
    • Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
    • Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010;9:119-128.
    • (2010) Lancet Neurol , vol.9 , pp. 119-128
    • Jack, C.R.1    Knopman, D.S.2    Jagust, W.J.3
  • 3
    • 0026740795 scopus 로고
    • Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
    • Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42:631-639.
    • (1992) Neurology , vol.42 , pp. 631-639
    • Arriagada, P.V.1    Growdon, J.H.2    Hedley-Whyte, E.T.3    Hyman, B.T.4
  • 4
    • 0038117796 scopus 로고    scopus 로고
    • Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline
    • Naslund J, Haroutunian V, Mohs R, et al. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 2000;283:1571-1577.
    • (2000) JAMA , vol.283 , pp. 1571-1577
    • Naslund, J.1    Haroutunian, V.2    Mohs, R.3
  • 5
    • 1842510004 scopus 로고    scopus 로고
    • Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
    • Ingelsson M, Fukumoto H, Newell KL, et al. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 2004;62:925-931.
    • (2004) Neurology , vol.62 , pp. 925-931
    • Ingelsson, M.1    Fukumoto, H.2    Newell, K.L.3
  • 6
    • 67349184808 scopus 로고    scopus 로고
    • Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease
    • Price JL, McKeel DW Jr, Buckles VD, et al. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging 2009;30:1026-1036.
    • (2009) Neurobiol Aging , vol.30 , pp. 1026-1036
    • Price, J.L.1    McKeel, D.W.2    Buckles, V.D.3
  • 7
    • 35648932901 scopus 로고    scopus 로고
    • Beta-amyloid imaging and memory in non-demented individuals: Evidence for preclinical Alzheimer's disease
    • Pike KE, Savage G, Villemagne VL, et al. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain 2007;130: 2837-2844.
    • (2007) Brain , vol.130 , pp. 2837-2844
    • Pike, K.E.1    Savage, G.2    Villemagne, V.L.3
  • 8
    • 73349125078 scopus 로고    scopus 로고
    • Differential association of [11C]PIB and [18F]FDDNP binding with cognitive impairment
    • Tolboom N, van der Flier WM, Yaqub M, et al. Differential association of [11C]PIB and [18F]FDDNP binding with cognitive impairment. Neurology 2009;73:2079-2085.
    • (2009) Neurology , vol.73 , pp. 2079-2085
    • Tolboom, N.1    Van Der Flier, W.M.2    Yaqub, M.3
  • 9
    • 77950538370 scopus 로고    scopus 로고
    • Cognition, reserve, and amyloid deposition in normal aging
    • Rentz DM, Locascio JJ, Becker JA, et al. Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol 2010;67:353-364.
    • (2010) Ann Neurol , vol.67 , pp. 353-364
    • Rentz, D.M.1    Locascio, J.J.2    Becker, J.A.3
  • 10
    • 79960199327 scopus 로고    scopus 로고
    • Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
    • Pike KE, Ellis KA, Villemagne VL, et al. Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study. Neuropsychologia 2011;49:2384-2390.
    • (2011) Neuropsychologia , vol.49 , pp. 2384-2390
    • Pike, K.E.1    Ellis, K.A.2    Villemagne, V.L.3
  • 11
    • 84857776667 scopus 로고    scopus 로고
    • APOE modifies the association between Ab load and cognition in cogni-tively normal older adults
    • Kantarci K, Lowe V, Przybelski SA, et al. APOE modifies the association between Ab load and cognition in cogni-tively normal older adults. Neurology 2012;78:232-240.
    • (2012) Neurology , vol.78 , pp. 232-240
    • Kantarci, K.1    Lowe, V.2    Przybelski, S.A.3
  • 12
    • 84870503989 scopus 로고    scopus 로고
    • Amyloid deposition detected with flor-betapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals
    • Sperling RA, Johnson KA, Doraiswamy PM, et al; AV45-A05 Study Group. Amyloid deposition detected with flor-betapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals. Neurobiol Aging 2013;34:822-831.
    • (2013) Neurobiol Aging , vol.34 , pp. 822-831
    • Sperling, R.A.1    Johnson, K.A.2    Doraiswamy, P.M.3
  • 13
    • 73549106106 scopus 로고    scopus 로고
    • Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: Cognitive decline associated with Abeta deposition
    • Storandt M, Mintun MA, Head D, Morris JC. Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition. Arch Neurol 2009;66:1476-1481.
    • (2009) Arch Neurol , vol.66 , pp. 1476-1481
    • Storandt, M.1    Ma, M.2    Head, D.3    Morris, J.C.4
  • 14
    • 77949408552 scopus 로고    scopus 로고
    • Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C] PiB
    • Resnick SM, Sojkova J, Zhou Y, et al. Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB. Neurology 2010;74:807-815.
    • (2010) Neurology , vol.74 , pp. 807-815
    • Resnick, S.M.1    Sojkova, J.2    Zhou, Y.3
  • 15
    • 79551495391 scopus 로고    scopus 로고
    • Longitudinal assessment of Ab and cognition in aging and Alzheimer disease
    • Villemagne VL, Pike KE, Chételat G, et al. Longitudinal assessment of Ab and cognition in aging and Alzheimer disease. Ann Neurol 2011;69:181-192.
    • (2011) Ann Neurol , vol.69 , pp. 181-192
    • Villemagne, V.L.1    Pike, K.E.2    Chételat, G.3
  • 16
    • 84864944776 scopus 로고    scopus 로고
    • CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects
    • Ewers M, Insel P, Jagust WJ, et al; Alzheimer's Disease Neuroimaging Initiative (ADNI). CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects. Cereb Cortex 2012;22:1993-2004.
    • (2012) Cereb Cortex , vol.22 , pp. 1993-2004
    • Ewers, M.1    Insel, P.2    Jagust, W.J.3
  • 17
    • 84862735174 scopus 로고    scopus 로고
    • Amyloid deposition, hypometabolism, and longitudinal cognitive decline
    • Landau SM, Mintun MA, Joshi AD, et al. Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann Neurol 2012;72:578-586.
    • (2012) Ann Neurol , vol.72 , pp. 578-586
    • Landau, S.M.1    Ma, M.2    Joshi, A.D.3
  • 18
    • 84871200927 scopus 로고    scopus 로고
    • Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults
    • Lim YY, Ellis KA, Pietrzak RH, et al. Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. Neurology 2012;79:1645-1652.
    • (2012) Neurology , vol.79 , pp. 1645-1652
    • Lim, Y.Y.1    Ellis, K.A.2    Pietrzak, R.H.3
  • 19
    • 84871195205 scopus 로고    scopus 로고
    • Amyloid-b assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study
    • Doraiswamy PM, Sperling RA, Coleman RE, et al: AV45-A11 Study Group. Amyloid-b assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study. Neurology 2012;79:1636-1644.
    • (2012) Neurology , vol.79 , pp. 1636-1644
    • Doraiswamy, P.M.1    Sperling, R.A.2    Coleman, R.E.3
  • 20
    • 84872463568 scopus 로고    scopus 로고
    • Rapid decline in episodic memory in healthy older adults with high amyloid-b
    • Lim YY, Pietrzak RH, Ellis KA, et al. Rapid decline in episodic memory in healthy older adults with high amyloid-b. J Alzheimers Dis 2013;33:675-679.
    • (2013) J Alzheimers Dis , vol.33 , pp. 675-679
    • Lim, Y.Y.1    Pietrzak, R.H.2    Ellis, K.A.3
  • 21
    • 84873392475 scopus 로고    scopus 로고
    • Decline in cognitive function over 18 months in healthy older adults with high amyloid-b
    • Ellis KA, Lim YY, Harrington K, et al. Decline in cognitive function over 18 months in healthy older adults with high amyloid-b. J Alzheimers Dis 2013;34:861-871.
    • (2013) J Alzheimers Dis , vol.34 , pp. 861-871
    • Ellis, K.A.1    Lim, Y.Y.2    Harrington, K.3
  • 22
    • 84876205585 scopus 로고    scopus 로고
    • Cognitive trajectories associated with b-amyloid deposition in the oldest-old without dementia
    • Snitz BE, Weissfeld LA, Lopez OL, et al. Cognitive trajectories associated with b-amyloid deposition in the oldest-old without dementia. Neurology 2013;80:1378-1384.
    • (2013) Neurology , vol.80 , pp. 1378-1384
    • Snitz, B.E.1    Weissfeld, L.A.2    Lopez, O.L.3
  • 23
    • 84892765470 scopus 로고    scopus 로고
    • Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease
    • Lim YY, Maruff P, Pietrzak RH, et al. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease. Brain 2014;137:221-231.
    • (2014) Brain , vol.137 , pp. 221-231
    • Lim, Y.Y.1    Maruff, P.2    Pietrzak, R.H.3
  • 24
    • 55949117032 scopus 로고    scopus 로고
    • Frequent amyloid deposition without significant cognitive impairment among the elderly
    • Aizenstein HJ, Nebes RD, Saxton JA, et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol 2008;65:1509-1517.
    • (2008) Arch Neurol , vol.65 , pp. 1509-1517
    • Aizenstein, H.J.1    Nebes, R.D.2    Saxton, J.A.3
  • 25
    • 84858341309 scopus 로고    scopus 로고
    • Cerebrovas-cular disease, b-amyloid, and cognition in aging
    • Marchant NL, Reed BR, DeCarli CS, et al. Cerebrovas-cular disease, b-amyloid, and cognition in aging. Neuro-biol Aging 2012;33:1006.e1025-e1036.
    • (2012) Neuro-biol Aging , vol.33 , pp. 1006e1025-1006e1036
    • Marchant, N.L.1    Reed, B.R.2    DeCarli, C.S.3
  • 26
    • 66549106850 scopus 로고    scopus 로고
    • Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease
    • Jack CR Jr, Lowe VJ, Weigand SD, et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 2009;132:1355-1365.
    • (2009) Brain , vol.132 , pp. 1355-1365
    • Jack, C.R.1    Lowe, V.J.2    Weigand, S.D.3
  • 27
    • 79956098248 scopus 로고    scopus 로고
    • Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
    • Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:280-292.
    • (2011) Alzheimers Dement , vol.7 , pp. 280-292
    • Sperling, R.A.1    Aisen, P.S.2    Beckett, L.A.3
  • 28
    • 84865529158 scopus 로고    scopus 로고
    • Clinical and biomarker changes in dominantly inherited Alzheimer's disease
    • Bateman RJ, Xiong C, Benzinger TL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012;367:795-804.
    • (2012) N Engl J Med , vol.367 , pp. 795-804
    • Bateman, R.J.1    Xiong, C.2    Benzinger, T.L.3
  • 29
    • 84878794559 scopus 로고    scopus 로고
    • Developing an international network for Alzheimer research: The Domi-nantly Inherited Alzheimer Network
    • Morris JC, Aisen PS, Bateman RJ, et al. Developing an international network for Alzheimer research: The Domi-nantly Inherited Alzheimer Network. Clin Investig (Lond) 2012;2:975-984.
    • (2012) Clin Investig (Lond) , vol.2 , pp. 975-984
    • Morris, J.C.1    Aisen, P.S.2    Bateman, R.J.3
  • 30
    • 0027425211 scopus 로고
    • The Clinical Dementia Rating (CDR): Current version and scoring rules
    • Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
    • (1993) Neurology , vol.43 , pp. 2412-2414
    • Morris, J.C.1
  • 32
    • 84856541277 scopus 로고    scopus 로고
    • Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families
    • Cruchaga C, Haller G, Chakraverty S, et al. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families. PLoS One 2012;7:e31039.
    • (2012) PLoS One , vol.7 , pp. e31039
    • Cruchaga, C.1    Haller, G.2    Chakraverty, S.3
  • 33
    • 84891481919 scopus 로고    scopus 로고
    • Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN)
    • Storandt M, Balota DA, Aschenbrenner AJ, Morris JC. Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN). Neuropsychology 2014;28:19-29.
    • (2014) Neuropsychology , vol.28 , pp. 19-29
    • Storandt, M.1    Balota, D.A.2    Aschenbrenner, A.J.3    Morris, J.C.4
  • 34
    • 84888089112 scopus 로고    scopus 로고
    • Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease
    • Benzinger TL, Blazey T, Jack CR Jr, et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci USA 2013;110: E4502-E4509.
    • (2013) Proc Natl Acad Sci USA , vol.110 , pp. E4502-E4509
    • Benzinger, T.L.1    Blazey, T.2    Jack, C.R.3
  • 35
    • 84892402771 scopus 로고    scopus 로고
    • Quantitative analysis of PiB-PET with FreeSurfer ROIs
    • Su Y, D'Angelo GM, Vlassenko AG, et al. Quantitative analysis of PiB-PET with FreeSurfer ROIs. PLoS One 2013;8:e73377.
    • (2013) PLoS One , vol.8 , pp. e73377
    • Su, Y.1    D'Angelo, G.M.2    Vlassenko, A.G.3
  • 36
    • 84917726968 scopus 로고    scopus 로고
    • Partial volume correction in quantitative amyloid imaging
    • Su Y, Blazey TM, Snyder AZ, et al. Partial volume correction in quantitative amyloid imaging. Neuroimage 2015;107:55-64.
    • (2015) Neuroimage , vol.107 , pp. 55-64
    • Su, Y.1    Blazey, T.M.2    Snyder, A.Z.3
  • 37
    • 33747048954 scopus 로고    scopus 로고
    • PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
    • Mintun MA, Larossa GN, Sheline YI, et al. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 2006;67:446-452.
    • (2006) Neurology , vol.67 , pp. 446-452
    • Ma, M.1    Larossa, G.N.2    Sheline, Y.I.3
  • 38
    • 84905868699 scopus 로고    scopus 로고
    • Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis
    • Ryman DC, Acosta-Baena N, Aisen PS, et al. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology 2014;83:253-260.
    • (2014) Neurology , vol.83 , pp. 253-260
    • Ryman, D.C.1    Acosta-Baena, N.2    Aisen, P.S.3
  • 39
    • 84876385490 scopus 로고    scopus 로고
    • Meta-analysis of amyloid-cognition relations in cognitively normal older adults
    • Hedden T, Oh H, Younger AP, Patel TA. Meta-analysis of amyloid-cognition relations in cognitively normal older adults. Neurology 2013;80:1341-1348.
    • (2013) Neurology , vol.80 , pp. 1341-1348
    • Hedden, T.1    Oh, H.2    Younger, A.P.3    Patel, T.A.4
  • 40
    • 84911430470 scopus 로고    scopus 로고
    • Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease
    • Sassi C, Guerreiro R, Gibbs R, et al. Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease. Neurobiol Aging 2014;35: 2881.e2881-e2886.
    • (2014) Neurobiol Aging , vol.35 , pp. e2881-e2886
    • Sassi, C.1    Guerreiro, R.2    Gibbs, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.